Regulus Therapeutics | RGLS - Acreedores Comerciales



Acreedores Comerciales Cambio Fecha
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Biogen USD 432M 18.9M 2025-12
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Immunic USD 7.92M 25K 2025-09
Incyte USD 1.63B 1.46B 2025-12
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Lexicon Pharmaceuticals USD 3.08M 714K 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Merck USD 4.15B 102M 2025-09
Omeros USD 8.84M 4.42M 2025-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 2.89B 2025-12
Takeda JPY 467.59B 28.61B 2025-12